Skip to main content
Clinical Trials/JPRN-UMIN000004188
JPRN-UMIN000004188
Completed
未知

A prospective, randomized controlled trial comparing alendronate and alendronate plus alphacalcidol therapy in patients with steroid-induced osteoporosis accompanied with interstitial pneumonias - Steroid-induced osteoporosis accompanied with interstitial pneumonias

agasaki University School of Medicine0 sites60 target enrollmentSeptember 10, 2010

Overview

Phase
未知
Intervention
Not specified
Conditions
interstitial pneumonias
Sponsor
agasaki University School of Medicine
Enrollment
60
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 10, 2010
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
agasaki University School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\) The patients who have severe complications (2\) The patients who have the diseases of bone metabolism (3\) The patients who were administered steroid therapy within a year (4\) The patients who are administered therapy affecting bone metabolism (5\) The patients who have fracture or scoliosis at 3rd to 5th lumbar (6\) The patients who have impaired renal function (Cr \> 1\.5mg/dl) (7\) The patients who are contraindicated to take alendronate or alphacalcidol (8\) The patients who are pregnant (9\) The patients who attended clinical trials within three months

Outcomes

Primary Outcomes

Not specified

Similar Trials